Live Breaking News & Updates on Catalys Pacific

Stay updated with breaking news from Catalys pacific. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Catalys Pacific LLC Makes New Investment in Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT)

Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […] ....

United States , New Zealand General , New Zealand , Terrie Curran , Stifel Nicolaus , Molly Henderson , Catalys Pacific , News Ratings For Phathom Pharmaceuticals Daily , Phathom Pharmaceuticals Stock Performance , Quarter For Phathom Pharmaceuticals , Phathom Pharmaceuticals Inc , Principal Financial Group Inc , Insider Activity At Phathom Pharmaceuticals , Barclays Plc , Securities Exchange Commission , Wellington Management Group , Exchange Commission , Needham Company , Phathom Pharmaceuticals Profile , Inspirion Wealth Advisors , Phathom Pharmaceuticals , Free Report , Financial Group , Management Group , Wealth Advisors , Get Free Report ,

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 723 Shares

HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 723 Shares
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Aditya Kohli , Franklin Resources Inc , Hillevax Inc , Securities Exchange Commission , Swiss National Bank , Catalys Pacific , Hillevax Company Profile , Mokshaco Inc , Sg Americas Securities , Get Free Report , Director Aditya Kohli , Exchange Commission , Vax Stock Down , National Bank , Hillevax Daily ,

HilleVax (NASDAQ:HLVX) Shares Gap Up to $12.02

Shares of HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.02, but opened at $12.58. HilleVax shares last traded at $11.99, with a volume of 1,768 shares. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price […] ....

Robert Hershberg , Aditya Kohli , Catalys Pacific , Acuta Capital Partners , Mokshaco Inc , Hillevax Inc , Deerfield Management Companylp Series , Get Free Report , Director Aditya Kohli , Capital Partners , Adage Capital Partners , Hillevax Daily ,

Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan

Renalys Pharma Submits an IND Application for a Phase III Clinical Trial of sparsentan for IgA Nephropathy in Japan
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Chuo Ku , Republic Of , South Korea , Catalys Pacific , Renalys Pharma , Prnewswire Renalys Pharma Inc , Company Name , Travere Therapeutics Inc , Devices Agency , Renalys Pharma Inc , Pharma Submits , Iga Nephropathy , Investigational New Drug , Medical Devices Agency , Travere Therapeutics , New Drug Application ,